Cite
Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2−Negative Postmenopausal Breast Cancer Patients
MLA
Perez-Tenorio, Jenny Pousette, et al. “Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (STILs) in ER-Positive/HER2−Negative Postmenopausal Breast Cancer Patients.” Cancers; Volume 14; Issue 19; Pages: 4844, Oct. 2022. EBSCOhost, https://doi.org/10.3390/cancers14194844.
APA
Perez-Tenorio, J. P., Annelie Johansson, Carolin Jönsson, Tommy Fornander, Linda S. Lindström, Hans Olsson, & Gizeh. (2022). Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (sTILs) in ER-Positive/HER2−Negative Postmenopausal Breast Cancer Patients. Cancers; Volume 14; Issue 19; Pages: 4844. https://doi.org/10.3390/cancers14194844
Chicago
Perez-Tenorio, Jenny Pousette, Annelie Johansson, Carolin Jönsson, Tommy Fornander, Linda S. Lindström, Hans Olsson, and Gizeh. 2022. “Prognostic and Predictive Significance of Stromal Tumor-Infiltrating Lymphocytes (STILs) in ER-Positive/HER2−Negative Postmenopausal Breast Cancer Patients.” Cancers; Volume 14; Issue 19; Pages: 4844, October. doi:10.3390/cancers14194844.